GSK’s plans to build a new life science campus in the UK are moving closer after securing partners for the project
When the hat fits: GSK boss Emma Walmsley
GSK’s plans to build a new life sciences campus in the UK have moved a step closer after it secured partners for the project.
The asset management arm of Swiss investment bank UBS has teamed up with London-based property developer Reef Group to form a joint venture that will build a campus in Stevenage, Hertfordshire.
The venture will bring £900m of investment for the site, which will be one of the largest of its kind in Europe.
The campus is to create 5,000 new high-skilled jobs as part of chief executive Emma Walmsley’s plan to reposition GSK as a life sciences innovator.
GSK will sell 33 acres of land to develop the new campus, which is due to open in 2025.
It will be built next to GSK’s existing research and development center in Stevenage.
“The campus will add laboratory space and space to accommodate new companies here,” said Tony Wood, GSK’s chief scientific officer.
GSK’s plans to build a new life sciences campus in the UK are a step closer
Source link GSK’s plans to build a new life sciences campus in the UK are a step closer